Will Kennedy review of US FDA vaccine committee being independant of BIG PHARHA influence cause genuine change and include support of regulator controlled trials and studies like UK MHRA did for VIRALEZE™ in UK NHS Hospital
WHY DIDN’T WHO CONTROL THE BIG PICTURE AND FALL FOR WARLORD BIG PHARMA PROFITEERING
It was a simple formula when COVID-19 began in 2020:
1️⃣ Find a vaccine
2️⃣ Find a treatment
The strategy: vaccinate the world and treat the sick — herd immunity would follow.
But it was flawed. COVID-19 wasn’t like polio, measles, smallpox, or shingles — where one shot gives long-term protection or leads to elimination.
COVID is a respiratory virus like flu, RSV, or the common cold. No vaccine has ever lasted even a year for these. Over an 80-year lifespan, that means 100+ muscle jabs.
In 2020, VIRALEZE™ emerged — a preventive nasal spray that kills COVID and other viruses on contact. Like sunscreen or toothpaste, regular use could protect entire communities.
But in 2021, rushed mRNA vaccines needed global rollout and guaranteed markets. Big Pharma used its full influence: lobbying, donations, committee positions, media control. This battle couldn’t be lost.
Manufacturing scale gave Big Pharma a monopoly — any threat to profit (like cheap, broad preventives) had to be stopped.
So prevention messaging was restricted to the visible: handwashing, masks, surface wipes — while denying airborne spread and censoring nasal sprays.
A market was secured: repeat jabs every year, forever.
By 2021, info control (via TNI and government “truth” campaigns) ensured that simple, safe alternatives like VIRALEZE™ were buried.
There are thousands of pages to this story. Perhaps one day a corruption commission will expose it.
Regulators must serve public health, not corporate profit. Science must be independent — not outsourced to pharma-funded trials
- Forums
- ASX - By Stock
- SPL
- The big picture - why nasal sprays were doomed
SPL
starpharma holdings limited
Add to My Watchlist
3.87%
!
9.4¢

The big picture - why nasal sprays were doomed
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.4¢ |
Change
0.004(3.87%) |
Mkt cap ! $39.31M |
Open | High | Low | Value | Volume |
9.0¢ | 9.4¢ | 9.0¢ | $21.86K | 237.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 120141 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 13999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70141 | 0.092 |
2 | 62948 | 0.090 |
1 | 50000 | 0.088 |
2 | 185167 | 0.087 |
1 | 10000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 13999 | 2 |
0.095 | 78337 | 7 |
0.098 | 28000 | 1 |
0.099 | 280650 | 10 |
0.100 | 50250 | 7 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |